Jurors hear final arguments in opioid bribe scheme case


BOSTON (AP) — In a scheme to get doctors to write prescriptions in exchange for cash, a wealthy drug company founder put patients at risk to guarantee his business’ success, a federal prosecutor told jurors Thursday in his closing arguments in the closely-watched trial.

Meanwhile, an attorney for Insys Therapeutics Founder John Kapoor sought to poke holes in the government’s case, calling its two star witnesses liars with conflicting stories and accusing prosecutors of targeting Kapoor so just so they can tout a high-profile conviction.

“The story cannot be true and they don’t care because they have had their eye on this man, and these people for years,” Attorney Beth Wilkinson said. “They want to show that they can take the guy at the top … and they don’t care if the other guys make up their story,” she said.

Kapoor and four other former executives of the Chandler, Arizona-based company are charged with conspiring to pay doctors millions of dollars in the form of fees for sham speaking events about the drug — a highly addictive fentanyl spray meant for patients with severe cancer pain.

Prosecutors said Insys staffers also misled insurers about patients’ medical conditions and posed as doctors’ office employees in order to get payment approved for the costly opioid.

Biden Snubs Brazilian President by Walking Offstage Without Handshake, Viral Reaction Says It All

Assistant U.S. Attorney Nathaniel Yeager told jurors that Kapoor and the others targeted reckless prescribers and tracked how much money the company got in return for the bribes because they were consumed by their own financial gain.

“First, do no harm became: First do what you’re told. First, do what you agreed to do. First, before the patient, take care of us,” Yeager said.

One of the government’s star witnesses was the company’s former vice president of sales who’s cooperating for the chance at a lighter sentence. Alec Burlakoff, who pleaded guilty, told jurors last month that Insys sought out as “business partners” doctors who were known to write lots of prescriptions for people who didn’t need it.

“Pill mills for us meant dollar signs,” Burlakoff said. “It was not run the other way. It was run to the pill mill.”

Wilkinson said Burlakoff was the one plotting the scheme with doctors and that he and former CEO Michael Babich are lying in order to protect themselves.

She also blasted prosecutors for trying to paint the drug as dangerous, arguing that it legitimately helped people suffering from serious pain. Kapoor invested heavily in the company because he truly believed in the power of the drug, she said.

“He had every reason to believe that this was good for patients. And he put his money where his mouth is,” she said.

Closing arguments are expected to continue Friday in the case, which began in January.


Fox's Brian Kilmeade Calls KJP's Border Comments 'The Most Worthless Series of Sentences I Could Imagine'

Follow Alanna Durkin Richer at

The Western Journal has not reviewed this Associated Press story prior to publication. Therefore, it may contain editorial bias or may in some other way not meet our normal editorial standards. It is provided to our readers as a service from The Western Journal.

Truth and Accuracy

Submit a Correction →

We are committed to truth and accuracy in all of our journalism. Read our editorial standards.

The Associated Press is an independent, not-for-profit news cooperative headquartered in New York City. Their teams in over 100 countries tell the world’s stories, from breaking news to investigative reporting. They provide content and services to help engage audiences worldwide, working with companies of all types, from broadcasters to brands. Photo credit: @AP on Twitter
The Associated Press was the first private sector organization in the U.S. to operate on a national scale. Over the past 170 years, they have been first to inform the world of many of history's most important moments, from the assassination of Abraham Lincoln and the bombing of Pearl Harbor to the fall of the Shah of Iran and the death of Pope John Paul.

Today, they operate in 263 locations in more than 100 countries relaying breaking news, covering war and conflict and producing enterprise reports that tell the world's stories.
New York City